Soluble cytokine

Soluble cytokines are a broad category of small, secreted proteins that act as essential mediators of cell-to-cell communication, particularly within the immune system (PubMed: 25403290). They encompass several families, including interleukins, interferons, and tumor necrosis factors, which regulate biological processes such as inflammation, hematopoiesis, and wound healing (NIH: StatPearls - Cytokines). Pathologically, the over-expression or dysregulation of these molecules is a hallmark of many autoimmune diseases, such as rheumatoid arthritis, and acute conditions like cytokine release syndrome (PubMed: 32531131). Therapeutic strategies frequently employ monoclonal antibodies or soluble decoy receptors to neutralize these ligands in the extracellular space, thereby preventing them from activating their cognate cell-surface receptors. While these therapies have revolutionized the treatment of chronic inflammatory diseases, they carry risks of systemic immunosuppression and increased susceptibility to infections (PubMed: 21464377). Common examples of targeted soluble cytokines include Tumor necrosis factor-alpha and Interleukin-1 beta, which are central to the pathogenesis of various systemic inflammatory disorders. Monitoring of these targets often involves measuring serum protein levels or downstream inflammatory markers like C-reactive protein to assess disease activity and treatment response.

Other names

CytokinesInterleukinsChemokinesInterferonsLymphokinesMonokinesSoluble inflammatory mediators

Drugs targeting soluble cytokines typically function as neutralizing agents, such as monoclonal antibodies or decoy receptors, which bind to the soluble ligand and prevent it from interacting with its cell-surface receptor, thereby inhibiting downstream signaling pathways.